Cargando…
How has the coronavirus pandemic impacted chemoradiotherapy for stage 3 non-small cell lung cancer (NSCLC) in our centre?
Autores principales: | Kathirgamakarthigeyan, Sangary, Foweraker, Karen, Johnson, Kerstie, Sivanandan, M. Ananth, Pascoe, Abigail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829818/ http://dx.doi.org/10.1016/S0169-5002(22)00075-7 |
Ejemplares similares
-
The impact of COVID-19 on national targets in radical lung cancer radiotherapy: a single centre clinical audit
por: Durno, Kimberley, et al.
Publicado: (2022) -
Patient and physician opinion of virtual care in the oncology department of an Irish tertiary care centre in the era of Covid-19
por: O’Reilly, Mary, et al.
Publicado: (2021) -
Delivering bronchoscopy and respiratory diagnostic service for lung cancer during COVID-19 pandemic: a single-centre experience
por: Yeo, Sue-Lis, et al.
Publicado: (2021) -
Maintaining flexible bronchoscopy and endobronchial ultrasound (EBUS) services during the COVID-19 pandemic at a tertiary centre: the Manchester Royal Infirmary experience
por: Nasr, Eman, et al.
Publicado: (2021) -
The effect of COVID-19 on the presentation, staging, and treatment of lung cancer: a retrospective comparative audit of the ‘first wave’
por: Evetts, Lisa, et al.
Publicado: (2021)